BioBots creates 3D bioprinters and bioinks that are unleashing the biological revolution.
"We are very glad to be one of the labs that bought this printer and explored its function. In general, this system is very convenient to use, the interface is user friendly, and the printer works stable. I personally like it very much."
Dr. Zaozao Chen
"Working with BioBots has allowed us to embark on new directions in research to answer important questions in tissue engineering and disease modeling. The bioprinters are cleverly designed, cost-efficient, and very user friendly. The company itself is forward-thinking, energetic, and truly committed to helping scientists make advances in 3D bioprinting."
Angela Panoskaltsis-Mortari, PhD
"Personalized medicine is the future -- and BioBots is helping to shape it."
"At a lab in Philadelphia's Drexel University, a desktop 3-D printer is cranking out miniature samples of bones. In Toronto, another researcher is using the same printer to make living tumors for drug testing. It looks like an ordinary 3-D printer, but instead of plastic, it squirts out living cells.
BioBots, the startup behind the device, wants to change how researchers do biology."
"U.S. biotech startup BioBots sits at the intersection between computer science and chemistry. Its debut product, a desktop 3D printer for biomaterials, which was just demoed on stage at TechCrunch Disrupt NY — printing Van Gogh’s ear in replica, no less — combines hardware, software and wetware. It’s the latter area where the core innovation sits"
"the BioBot offers plug-and-play desktop bioprinting, something that could transform medicine in a host of ways, including testing the toxicity of new drugs on potential patients."
"desktop bioprinter developed by two University of Pennsylvania grads lets nearly anyone print living tissue."
"Just add a few living cells to the bio-ink, print it out of the BioBot, give it a little time, and grow new cartilage, or someday, perhaps a kidney."
"3D bioprinting technology startup, BioBots, is seeking to disrupt the nascent field of bioprinting with its new printer for 3D living tissue creation. At only USD$5,000 per printer, I would say they are off to a pretty good start."
"This low-cost, desktop bioprinter, gives big and small companies or institutions (such as university research labs), a chance to develop 3D organ models with human cells in their own lab."
"With more affordable bioprinters like BioBots, the technology becomes more democratized and research developments can happen faster."
